Claudia Varela

Ms. Claudia Varela

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 August 2019 in Science Robotics
Verified
Journal Article
Open access
PDF file
EDEimear Dolan
Eimear Dolan
CVClaudia Varela
Claudia Varela
KMK. Mendez
K. Mendez
WWW. Whyte
W. Whyte
RLR. E. Levey
R. E. Levey
EREllen Roche
Ellen Roche
The performance of indwelling medical devices that depend on an interface with soft tissue is plagued by complex, unpredictable foreign body responses. Such devices—including breast implants, biosensors, and drug delivery devices—are often subject to a collection of biological host responses, including fibrosis, which can impair device functionality. This work describes a milliscale dynamic soft reservoir (DSR) that actively modulates the biomechanics of the biotic-abiotic interface by altering strain, fluid flow, and cellular activity in the peri-implant tissue. We performed cyclical actuation of the DSR in a preclinical rodent model. Evaluation of the resulting host response showed a significant reduction in fibrous capsule thickness (P = 0.0005) in the actuated DSR compared with non-actuated controls, whereas the collagen density and orientation were not changed. We also show a significant reduction in myofibroblasts (P = 0.0036) in the actuated group and propose that actuation-mediated strain reduces differentiation and proliferation of myofibroblasts and therefore extracellular matrix production. Computational models quantified the effect of actuation on the reservoir and surrounding fluid. By adding a porous membrane and a therapy reservoir to the DSR, we demonstrate that, with actuation, we could (i) increase transport of a therapy analog and (ii) enhance pharmacokinetics and time to functional effect of an inotropic agent. The dynamic reservoirs presented here may act as a versatile tool to further understand, and ultimately to ameliorate, the host response to implantable biomaterials.

19 June 2024 in Science Translational Medicine
Verified
Journal Article
Closed access
JDJue Deng
Jue Deng
JWJingjing Wu
Jingjing Wu
XCXiaoyu Chen
Xiaoyu Chen
TSTiffany L. Sarrafian
Tiffany L. Sarrafian
CVClaudia Varela
Claudia Varela
XZXuanhe Zhao
Xuanhe Zhao
Current clinically used electronic implants, including cardiac pacing leads for epicardial monitoring and stimulation of the heart, rely on surgical suturing or direct insertion of electrodes to the heart tissue. These approaches can cause tissue trauma during the implantation and retrieval of the pacing leads, with the potential for bleeding, tissue damage, and device failure. Here, we report a bioadhesive pacing lead that can directly interface with cardiac tissue through physical and covalent interactions to support minimally invasive adhesive implantation and gentle on-demand removal of the device with a detachment solution. We developed 3D-printable bioadhesive materials for customized fabrication of the device by graft-polymerizing polyacrylic acid on hydrophilic polyurethane and mixing with poly(3,4-ethylenedioxythiophene):poly(styrenesulfonate) (PEDOT:PSS) to obtain electrical conductivity. The bioadhesive construct exhibited mechanical properties similar to cardiac tissue and strong tissue adhesion, supporting stable electrical interfacing. Infusion of a detachment solution to cleave physical and covalent cross-links between the adhesive interface and the tissue allowed retrieval of the bioadhesive pacing leads in rat and porcine models without apparent tissue damage. Continuous and reliable cardiac monitoring and pacing of rodent and porcine hearts were demonstrated for 2 weeks with consistent capture threshold and sensing amplitude, in contrast to a commercially available alternative. Pacing and continuous telemetric monitoring were achieved in a porcine model. These findings may offer a promising platform for adhesive bioelectronic devices for cardiac monitoring and treatment.

2 April 2021 in Science Advances
Verified
Journal Article
Open access
PDF file
MSManisha Singh
Manisha Singh
CVClaudia Varela
Claudia Varela
WWWilliam Whyte
William Whyte
MHMarkus A. Horvath
Markus A. Horvath
NTNigel C. S. Tan
Nigel C. S. Tan
TSTerry Steele
Terry Steele
A catheter-based device activates voltage-curable adhesives in situ for minimally invasive closure of vascular lumen defects.

17 January 2019 in Biomimetics
Verified
Journal Article
Open access
PDF file
CVClaudia Varela
Claudia Varela
YFYiling Fan
Yiling Fan
EREllen Roche
Ellen Roche
The mechanical reinforcement of the ventricular wall after a myocardial infarction has been shown to modulate and attenuate negative remodeling that can lead to heart failure. Strategies include wraps, meshes, cardiac patches, or fluid-filled bladders. Here, we review the literature describing these strategies in the two broad categories of global restraint and local reinforcement. We further subdivide the global restraint category into biventricular and univentricular support. We discuss efforts to optimize devices in each of these categories, particularly in the last five years. These include adding functionality, biomimicry, and adjustability. We also discuss computational models of these strategies, and how they can be used to predict the reduction of stresses in the heart muscle wall. We discuss the range of timing of intervention that has been reported. Finally, we give a perspective on how novel fabrication technologies, imaging techniques, and computational models could potentially enhance these therapeutic strategies.

2 December 2015 in Journal of Food Biochemistry
Verified
Journal Article
Closed access
PDF file
CVClaudia Varela
Claudia Varela
EFEmilie Fromentin
Emilie Fromentin
MRMarc Roller
Marc Roller
FVFrancisco Villarreal
Francisco Villarreal
IRIsrael Ramirez-Sanchez
Israel Ramirez-Sanchez

3 November 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
CVClaudia Varela
Claudia Varela
DMDavid S. Monahan
David S. Monahan
SIShahrin Islam
Shahrin Islam
WWWilliam Whyte
William Whyte
JBJean Bonnemain
Jean Bonnemain
EREllen Roche
Ellen Roche
Epicardial delivery of human follistatin-like 1 protein (FSTL1) induces significant cardiac benefit following a myocardial infarction (MI). However, the optimal dosing regimen for maximal therapeutic benefit has not yet been elucidated. To investigate the impact of multiple FSTL1 doses, without the confounding effects of multiple surgical procedures for multidose delivery, alternative delivery strategies are needed. Here, we use an epicardial reservoir that allows non-invasive delivery of additional doses after implantation to investigate the impact of single, double, and triple FSTL1 dose regimens in a rat model of MI. Multidose delivery of FSTL1 improves ejection fraction (3 doses), fractional shortening (1, 2 and 3 doses), and chamber stiffness (2 doses) 28 days after MI. Histologically, multiple FSTL1 doses increase ventricular wall thickness (2 and 3 doses) and reduce infarct size (1, 2, and 3 doses). We also demonstrate a dose-dependent increase in blood vessel number and density in the infarct zone, with three FSTL1 doses leading to the highest improvements. This study shows that multidose delivery of FSTL1 improves cardiac function, healing, and angiogenesis following MI. The epicardial delivery platform used here may be essential in optimizing dosing regimens of various bioagent combinations for a range of clinical indications.